Skip to content

SCHEDULE 13D/AAccepted May 15, 4:20 PM ET

Lantern Pharma Inc. SCHEDULE 13D/A

Bios Equity Partners, LP

sec.gov(opens the filing on sec.gov)

Accepted (ET)

4:20 PM

May 15, 2026

Filed

May 15, 2026

Documents

1

Size

39.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.